Note: Confidential treatment requested with respect to certain portions hereof denoted with “[***]” COLLABORATION AGREEMENTCollaboration Agreement • January 9th, 2018 • ITUS Corp • Patent owners & lessors • Florida
Contract Type FiledJanuary 9th, 2018 Company Industry JurisdictionTHIS AGREEMENT is entered into on November 17, 2017 (hereinafter “Effective Date) by and between H. Lee Moffitt Cancer Center and Research Institute, Inc. a non-profit Florida corporation organized pursuant to Section 1004.43, Florida Statutes, whose address is 12902 Magnolia Drive Tampa, Florida 33612 (“Moffitt”) and Certainty Therapeutics, Inc., a corporation duly organized under the laws of Delaware whose address is 3150 Almaden Expressway, Suite 250, San Jose, California 95118 (hereinafter "Company"). Moffitt and Company are hereinafter referred to individually as “Party” and collectively as “Parties.”
Confidential Treatment Requested by ITUS Corporation, IRS Employer Identification No. 11-2622630 ***CONFIDENTIAL TREATMENT REQUESTED*** Note: Confidential treatment requested with respect to certain portions hereof denoted with “[***]” SECOND...Collaborative Research Agreement • January 9th, 2018 • ITUS Corp • Patent owners & lessors
Contract Type FiledJanuary 9th, 2018 Company IndustryThis SECOND AMENDMENT TO THE COLLABORATIVE RESEARCH AGREEMENT (the “Second Amendment”) is made as of the 1st day of August, 2017 (the “Second Amendment Effective Date”) by and between THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY, a Pennsylvania nonprofit corporation (“Wistar”) and ANIXA DIAGNOSTIC CORPORATION, a Delaware corporation (“Collaborator”). Wistar and Collaborator shall be referred to herein collectively as the “Parties”
Note: Confidential treatment requested with respect to certain portions hereof denoted with “[***]” LICENSE AGREEMENTLicense Agreement • January 9th, 2018 • ITUS Corp • Patent owners & lessors • Pennsylvania
Contract Type FiledJanuary 9th, 2018 Company Industry JurisdictionThis LICENSE AGREEMENT (the “Agreement”) Is made as of the 13th day of November, 2017 (the “Effective Date”), by and between THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY, a nonprofit corporation organized and existing under the laws of the Commonwealth of Pennsylvania located at 3601 Spruce Street, Philadelphia, PA 19104 (“Wistar”), and Certainty Therapeutics, Inc., a corporation organized and existing under the laws of the State of Delaware with principal offices located at 3150 Almaden Expressway, Suite 250, San Jose, California 95118 (“Company”).